The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.
about
Contribution of metabolic reprogramming to macrophage plasticity and functionHypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)-Induced Pulmonary Hypertension.Role of prostacyclin in pulmonary hypertension.Epigenetic regulation of inflammatory cytokines and associated genes in human malignanciesComing to terms with tissue engineering and regenerative medicine in the lung.Pathophysiology and treatment of pulmonary hypertension in sickle cell diseaseChronic hypoxia does not cause wall thickening of intra-acinar pulmonary supernumerary arteriesMetabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension.Endothelial and Smooth Muscle Cell Interactions in the Pathobiology of Pulmonary Hypertension.Origin and production of inflammatory perivascular macrophages in pulmonary hypertension.Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming.Emerging concepts in smooth muscle contributions to airway structure and function: implications for health and disease.Hypoxia in tissue repair and fibrosis.Pulmonary vascular remodeling in pulmonary hypertension.Heritabilities and genetic correlations of pulmonary arterial pressure and performance traits in Angus cattle at high altitude.Epigenetics, inflammation and metabolism in right heart failure associated with pulmonary hypertension.Nestin-expressing vascular wall cells drive development of pulmonary hypertension.Absence of the inflammasome adaptor ASC reduces hypoxia-induced pulmonary hypertension in mice.Long-Term Chronic Intermittent Hypobaric Hypoxia in Rats Causes an Imbalance in the Asymmetric Dimethylarginine/Nitric Oxide Pathway and ROS Activity: A Possible Synergistic Mechanism for Altitude Pulmonary Hypertension?Update on novel targets and potential treatment avenues in pulmonary hypertension.Admission for COPD Exacerbation Is Associated with the Clinical Diagnosis of Pulmonary Hypertension: Results from a Retrospective Longitudinal Study of a Veteran Population.Hypoxia and Local Inflammation in Pulmonary Artery Structure and Function.Metabolic Reprogramming and Redox Signaling in Pulmonary Hypertension.Mitochondrial dysfunction and pulmonary hypertension: Cause, Effect or Both.Immune cells and autoantibodies in pulmonary arterial hypertension.A Time- and Compartment-Specific Activation of Lung Macrophages in Hypoxic Pulmonary Hypertension.Isolation and characterization of endothelial-to-mesenchymal transition cells in pulmonary arterial hypertension.Impaired Pulmonary Arterial Vasoconstriction and Nitric Oxide-Mediated Relaxation Underlie Severe Pulmonary Hypertension in the Sugen-Hypoxia Rat Model.Role of Nerve Growth Factor in Development and Persistence of Experimental Pulmonary Hypertension.Extracellular Cyclophilin A, Especially Acetylated, Causes Pulmonary Hypertension by Stimulating Endothelial Apoptosis, Redox Stress, and Inflammation.Central role of T helper 17 cells in chronic hypoxia-induced pulmonary hypertension.Arginase inhibitor attenuates pulmonary artery hypertension induced by hypoxia.NLRC3: A Novel Noninvasive Biomarker for Pulmonary Hypertension DiagnosisPrenatal treatment with rosiglitazone attenuates vascular remodeling and pulmonary monocyte influx in experimental congenital diaphragmatic hernia
P2860
Q28080959-7D7FF5A7-6D27-4A6B-A9ED-E77251D14F7EQ33920050-3473CF07-54A2-488B-917B-439F95649171Q35165100-83779B09-4ADE-4386-90D1-626FF69CC05CQ35178132-9E0DB7A7-480B-49F8-91AB-8ED4D688FFC6Q36122885-59B630D8-02A9-4DC0-AAE9-F79D7FF3E986Q36596861-27E1DA09-50D0-4624-AE4C-C173711D375DQ36597676-B364DCFF-60AE-4DF7-AFE5-D03A3F50E844Q36752368-2618ADF9-51AC-4702-9715-78B691D1F5C3Q36766005-A5D79BA1-4648-498F-B589-1825F6686850Q38601788-EB0C138E-EDAE-423A-8EEC-610856AAE6F7Q38668387-03CBAC9B-934F-4FF7-9378-1FDE2BBF18A7Q38811516-6D3DD070-9CDA-4DA4-BC20-D49DF8CD6C96Q38898935-E0C34914-3A66-4AB7-AA85-2AF2BB854B3BQ39057104-531DCCB8-5F2E-428A-9B67-154EF12F73B2Q39145056-F8D919CD-1290-4E85-A684-40D2CDB41DA5Q39382663-8C6A44BC-E048-470F-8ECC-261F9064A0E0Q40176131-933DABAB-44C2-4CE2-A66B-46DAC345D712Q41163325-F60739EA-1CED-4393-8C20-9D0C6D52A79DQ41971809-FE5F85A7-01B9-46FC-BBE3-122905787602Q42784219-B5622F26-4D2D-4FDF-B66F-CB2A565E5C5CQ45326440-15DA7ACA-CBB9-450E-B145-682073F5F031Q46280825-C2F38C92-97BC-4D9A-A432-BF966AD0557AQ47631019-B9AB83C3-F69F-494E-8666-187D797B88CEQ47726007-989118B1-E36F-411E-B6E9-2074AB2508E8Q47742357-FFBD4276-A82C-4263-9B9A-47228A4F79B1Q48150398-867A0C52-8C42-4353-87B3-664583E44C1EQ48313046-F0DFE4A0-3044-48A7-85CB-25F9E025C668Q50046005-09A87AD8-E29E-4A82-9FA9-49810E64A5A1Q50969268-C04E14C4-2AB8-4CCA-91B5-0AD2B9BDBC00Q51031209-11B3550A-B952-4300-B6A9-090413BEEAF5Q51132724-69237BF6-886F-4553-90C9-3ECEE4FD4A11Q51570732-9F67A364-BE6F-4BF9-B7AF-846E34B306BCQ57051327-9F11A632-959F-435D-80C9-1110F4D44995Q59136832-832075E5-DA41-4B6F-9AB9-1F67A88AFE27
P2860
The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The role of inflammation in hy ...... anisms to clinical phenotypes.
@ast
The role of inflammation in hy ...... anisms to clinical phenotypes.
@en
type
label
The role of inflammation in hy ...... anisms to clinical phenotypes.
@ast
The role of inflammation in hy ...... anisms to clinical phenotypes.
@en
prefLabel
The role of inflammation in hy ...... anisms to clinical phenotypes.
@ast
The role of inflammation in hy ...... anisms to clinical phenotypes.
@en
P2093
P2860
P1476
The role of inflammation in hy ...... anisms to clinical phenotypes.
@en
P2093
Jens M Poth
Karim C El Kasmi
Kurt R Stenmark
Mehdi A Fini
Steven C Pugliese
P2860
P304
P356
10.1152/AJPLUNG.00238.2014
P577
2014-11-21T00:00:00Z